Tvardi Therapeutics
Phase 2Tvardi Therapeutics is an award-winning biotech company in Houston, Texas, offering IPF Clinical Trials & Liver Cancer Clinical Trials across the United States.
Founded
2017
Focus
Small Molecules
About
Tvardi Therapeutics is an award-winning biotech company in Houston, Texas, offering IPF Clinical Trials & Liver Cancer Clinical Trials across the United States.
Funding History
2Total raised: $110M
Series B$80MSpindletop CapitalJan 15, 2022
Series A$30MSpindletop CapitalJun 15, 2020
Company Info
TypePrivate
Founded2017
LocationHouston, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile